Moderna Inc (MRNA)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-3,561,000	-2,224,000	-5,867,000	-5,968,000	-4,714,000	-3,466,000	1,207,000	4,784,000	8,362,000	11,765,000	14,055,000	14,638,000	12,202,000	7,061,515	3,494,879	598,166	-747,064	-598,819	-488,377	-506,718
Revenue (ttm)	US$ in thousands	3,229,000	5,076,000	5,052,000	5,155,000	6,826,000	9,097,000	10,486,000	14,708,000	18,810,000	20,675,000	22,284,000	21,933,000	17,736,000	11,016,375	6,199,591	2,013,033	274,490	55,668	56,790	38,378
Net profit margin		-110.28%	-43.81%	-116.13%	-115.77%	-69.06%	-38.10%	11.51%	32.53%	44.46%	56.90%	63.07%	66.74%	68.80%	64.10%	56.37%	29.71%	-272.16%	-1,075.70%	-859.97%	-1,320.33%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-3,561,000K ÷ $3,229,000K
= -110.28%

The net profit margin of Moderna Inc fluctuated significantly over the analyzed period. Starting from negative values in early 2020 and extending through mid-2024, the company experienced deep losses, with margins as low as -1320.33% in March 2020. However, there was a notable turnaround in the firm's profitability as it transitioned into positive territory in early 2021, with the net profit margin reaching 29.71%. The positive trend continued with increasing margins in subsequent quarters, peaking at 68.80% by the end of 2021. However, the net profit margin began to decline from the first quarter of 2022 onward, dropping to 44.46% by the end of December 2022. The downward trend persisted, resulting in negative margins once again, with figures ranging from -69.06% to -110.28% in the latter half of 2024. Overall, while Moderna experienced a strong resurgence in profitability after a period of losses, its net profit margin notably declined in the later stages of the analyzed period, signaling potential challenges in sustaining high levels of profitability.